RE-BVS – Piemonte Repository

Sfoglia per AUTORE
PARATORE C
Collezione AO Ordine Mauriziano

Items : 12

Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants. in Cancer medicine / Cancer Med. 2025 Feb;14(3):e70364. doi: 10.1002/cam4.70364.

2025
AO Ordine Mauriziano
AOU Novara

Bencardino K; Forti L; Spallanzani A; Paratore C; Bernardini I; Giommoni E; Mosconi S; Scartozzi M; Rodriquenz MG; Rapposelli IG; Niger M; Bittoni A; Palloni A; Carloni R; Bergamo F; Chiaravalli M; Gaule M; Cavaliere A; Macchini M; Giordano G; Vasile E; Garajova I; Bozzarelli S; Noventa S; Procaccio L; Salvatore L; di Marco M; Orsi G; Milella M; et alii...

Gut and local microbiota in patients with cancer: increasing evidence and potential clinical applications. in Critical reviews in oncology/hematology / Crit Rev Oncol Hematol. 2024 May;197:104328. doi: 10.1016/j.critrevonc.2024.104328. Epub 2024 Mar 13

2024
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano
AOU Città della Salute di Torino

Di Maio M; Novello S; Vellani G; Sperone P; Vignani F; Dionisio R; Ferrari G; Paratore C; Valsecchi AA;

Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv). in British journal of cancer / Br J Cancer. 2023 Mar;128(5):877-885. doi: 10.1038/s41416-022-02086-w. Epub 2022 Dec 8.

2023
AO Ordine Mauriziano
AOU Novara

Reni M; Cascinu S; Milella M; Forti L; Valente MM; Bernardino K; Tamburini E; Bernardini I; Niger M; Giommoni E; Peretti U; Spallanzani A; Paratore C; Procaccio L; Salvatore L; Bittoni A; Merelli B; Garajova I; De Lorenzo S; Rapposelli IG; Militello AM; Rodriquenz MG; Bozzarelli S; Noventa S; Scartozzi M; Vasile E; Di Marco M; Giordano G; Macchini M; et alii...

Analysis of phase III clinical trials in metastatic NSCLC to assess the correlation between QoL results and survival outcomes. in BMC medicine / BMC Med. 2023 Jul 3;21(1):234. doi: 10.1186/s12916-023-02953-0.

2023
ASL Torino 4
AO Ordine Mauriziano

Formisano L; Santaniello A; Viscardi G; Di Costanzo F; Paratore C; Napolitano F; Salomone F; Di Maio M; Servetto A; Bianco R;

Analysis of the adequacy of control arms in oncology randomised clinical trials published between 2017 and 2021: a meta-research study. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2023 Aug;189:112920. doi: 10.1016/j.ejca.2023.05.008. Epub 2023 May 15.

2023
ASL Cuneo 2
AO Cuneo
ASL Torino 4
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Di Liello R; Di Maio M; Perrone F; Fabi A; Tuninetti V; Turco F; Trastu F; Reale ML; Paratore C; Lombardi P; Marandino L; Mariniello A; Ghisoni E; Gargiulo P; Bungaro M; Caglio A; Gamba T; Rossi A; Audisio M; Aimar G;

Time trends in health-related quality of life assessment and reporting within publications of oncology randomised phase III trials: a meta-research study. in BMJ oncology / BMJ Oncol. 2023 Mar 2;2(1):e000021. doi: 10.1136/bmjonc-2022-000021. eCollection 2023.

2023
AO Cuneo
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Turco F; Perrone F; Tuninetti V; Rossi A; Paratore C; Gargiulo P; Gamba T; Di Liello R; Caglio A; Audisio M; Bungaro M; Reale ML; Aimar G; Mariniello A; Lombardi P; Ghisoni E; Di Maio M; Trastu F; Marandino L;

Comparing T Cell Subsets in Broncho-Alveolar Lavage (BAL) and Peripheral Blood in Patients with Advanced Lung Cancer. in Cells / Cells. 2022 Oct 14;11(20):3226. doi: 10.3390/cells11203226.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Sangiolo D; Righi L; Passiglia F; Di Maio M; Paratore C; Bungaro M; De Filippis M; Consito L; Mecca C; Bertaglia V; Carnio S; Capelletto E; Listì A; Reale ML; Rezmives NA; Tesauro M; Indellicati D; Tabbò F; Mariniello A; Novello S; Geuna M; Bironzo P;

Subgroup analyses in randomized phase III trials of systemic treatments in patients with advanced solid tumours: a systematic review of trials published between 2017 and 2020. in ESMO open / ESMO Open. 2022 Dec;7(6):100593. doi: 10.1016/j.esmoop.2022.100593. Epub 2022 Oct 12.

2022
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Reale ML; Perrone F; Mariniello A; Gargiulo P; Gamba T; Di Liello R; Caglio A; Bungaro M; Audisio M; Zichi C; Paratore C; Di Maio M;

Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey. in ESMO open / ESMO Open. 2021 Oct;6(5):100238. doi: 10.1016/j.esmoop.2021.100238. Epub 2021 Aug 13.

2021
AO Ordine Mauriziano
AOU Novara

Reni M; Milella M; Cascinu S; Militello AM; Valente MM; Forti L; Scartozzi M; Giommoni E; Macchini M; Tamburini E; Bencardino K; Mosconi S; Spallanzani A; Paratore C; Bernardini I; Peretti U; Penzo E; De Lorenzo S; Rodriquenz MG; Bittoni A; Garajova I; Tortora G; Rapposelli IG; Giordano G; Noventa S; Bozzarelli S; Niger M; Cavaliere A; Di Marco M; et alii...

Adoption of multiple primary endpoints in phase III trials of systemic treatments in patients with advanced solid tumours. A systematic review. in European journal of cancer (Oxford, England : 1990) / Eur J Cancer. 2021 May;149:49-60. doi: 10.1016/j.ejca.2021.03.007. Epub 2021 Apr 3.

2021
AO Ordine Mauriziano
AOU San Luigi di Orbassano

Perrone F; Gamba T; Caglio A; Bungaro M; Audisio M; Reale ML; Gargiulo P; Mariniello A; Di Maio M; Zichi C; Paratore C;

Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort. in ESMO open / ESMO Open. 2021 Feb;6(1):100032. doi: 10.1016/j.esmoop.2020.100032. Epub 2021 Jan 4.

2021
AO Ordine Mauriziano
AOU Novara

Reni M; Milella M; Cascinu S; Falconi M; Chiarazzo C; De Lorenzo S; De Braud F; Salvatore L; Melisi D; Simbolo M; Calzavara S; Carrera P; Macchini M; Gaule M; Valente MM; Orsi G; Paratore C; Forti LG; Ratti M; Avallone A; Stuppia L; Giordano G; De Vita F; Rapposelli IG; Centonze F; Rodriquenz MG; Di Marco MC; Niger M; Tortora G; et alii...

A review of molecularly targeted therapy in biliary tract carcinoma: what is the next step? in Exploration of targeted anti-tumor therapy / Explor Target Antitumor Ther. 2021;2(5):448-464. doi: 10.37349/etat.2021.00056. Epub 2021 Oct 31.

2021
AO Ordine Mauriziano

Di Maio M; De Vita F; Gamba T; Caglio A; Sperti E; Marino D; Zichi C; Paratore C; Aimar G;